“CUSTOM” Molecular Profiling for Clinical Cancer Drug Trials
August 27, 2013 | Terry Sharrer
Georgetown University’s Lombardi Comprehensive Cancer Center has conducted the first prospective clinical trial which used genetic analysis alone to determine treatments for patients with either non-small cell lung cancer, small cell lung cancer, or thymic cancer. Among other things, the trial called CUSTOM was able to do the sequencing and expressional analysis in a two week time frame for each patient. MORE